SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genentech (NYSE:DNA) formerly known as (NYSE:GNE) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (220)1/30/2009 8:35:58 AM
From: tom pope  Read Replies (1) | Respond to of 250
 
!!!!!!!!!

Not what I for one expected. Does this fit Mr Humer?

'An ironic man, with his sly stillness, and ambuscading ways,' wrote Thomas Carlyle in 'Sartor Resartus,' 'may be viewed as a pest to society.'



To: kenhott who wrote (220)1/30/2009 10:14:23 AM
From: tuck  Read Replies (1) | Respond to of 250
 
Hah! That moved the range of the 2011 Leaps down noticeably. Wonder if this plays like the attempt to munch Ventana. If so, the game will go well beyond April. Awaiting DNA's response.

For those who weren't following the Roche/Ventana saga, here's a link one can surf from:

Message 23737102

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News